Delivery Order SPE2DB22D3016-SPE2DB24FBEE1
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,456,444 units of the prescription drug tamsulosin hydrochloride 0.4 mg capsules. The contract is a Delivery Order valued at $12,195.08 and has a Firm Fixed Price pricing type. The award has a completion date of August 15, 2024. This contract supports the DLA Troop Support Medical program, which procures pharmaceutical and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,566,078,385 units of the medication Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $6,912.00 and a completion date of October 11, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract,...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,437.67, is for the delivery of 4,567,253 units of Tamsulosin HCL 0.4 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of February 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,156.72, is for the delivery of 4,567,908,356 units of the prescription drug Tamsulosin HCL 0.4 mg capsules. The contract is a firm-fixed price delivery order that runs through April 15, 2025. This contract award is not associated with a set-aside designation, indicating open...
This is a $12,920.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 1,000 units of the pharmaceutical product Tamsulosin HCl 0.4 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, that enables the government to efficiently procure a comprehensive range of medical...
This federal contract award, valued at $2,879.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules, with a performance period extending to April 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,943.88, is for the delivery of 1,000 units of the prescription drug Tamsulosin HCL 0.4 mg capsules. The contract type is Delivery Order, with a Firm Fixed Price pricing structure, and an ultimate completion date of July 11, 2024. This award does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, valued at $1,897.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,758,933 units of Tamsulosin HCL 0.4 mg capsules, a medication used for the treatment of benign prostatic hyperplasia. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 19, 2024. No set-aside designation was...
This federal contract award, valued at $1,912.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,683,725 units of Tamsulosin HCl 0.4 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is set for September 5, 2024. The contract was not set aside for a specific business type. This award is likely part of a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,595.50, is for the delivery of 4,567,760,063 capsules of Tamsulosin HCL 0.4 mg. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. This contract is not associated with a set-aside designation, indicating open competition....